精密がん診断検査市場レポート：2022-2032

Precision Cancer Diagnostic Test Market Report 2022-2032

レポート詳細精密がん診断検査市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なも... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年6月8日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	602	673	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

精密がん診断検査市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

機能的精密医療（FPM）モデルなどの技術の進歩
FPMの現実的な課題のいくつかは、工学と生物学の交差点で生まれた新しい技術を使って対処することができます。腫瘍の微小環境、特に細胞外マトリックスをシミュレートすることを目的とした技術は、大きな進歩を遂げました。臓器チップ（組織チップまたはマイクロフィジオロジーシステムと呼ばれることもある）は、腫瘍の微小環境内部のがんを描写するために実際に使用されている。このようなマイクロ流体デバイスは、通常、組織特異的な種類の細胞、細胞外マトリックスゲル、およびがん細胞で構成され、ヒト組織に存在する分子的・機械的シグナルを再現しようとするものである。臓器チップの利点として考えられるのは、薬の分布、薬物動態、薬力学、薬物毒性などを再現できることであります。

臓器チップをFPMに広く利用するための障害としては、薬物検査のスループットが低いこと、これらの装置の作成と操作に専門的なスキルが必要であること、などがある。薬物療法の間、細胞を本来の生息環境にとどめておくことも、腫瘍の状態をシミュレートする方法の一つである。これは、個々の腫瘍切片またはファインニードル生検に対する薬物治療で、免疫蛍光細胞死標識を使って薬物感受性を評価することができる。患者の腫瘍に直接埋め込むことができる薬物含有マイクロデバイスの使用も、FPMの有望なアプローチである。このようなマイクロデバイスに含まれる薬剤は周辺組織に影響を与える可能性があり、腫瘍を摘出した後に治療結果を実際に評価することができます。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 精密がん診断検査市場はどのように進化しているのか？
- 精密がん診断検査市場の推進要因と抑制要因は何か？
- 各精密がん診断検査サブマーケットセグメントは予測期間中にどのように成長し、これらのサブマーケットが2032年にどれだけの収益を占めるようになるのか?
- 2022年から2032年にかけて、各精密がん診断検査サブマーケットの市場シェアはどのように推移するのか？
- 2022年から2032年にかけて、市場全体の主なドライバーは何になるのか？
- 主要な精密がん診断検査市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国別市場が他を凌駕するのか?
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、予測期間中の展望は？
- これらの主要企業の精密がん診断検査プロジェクトはどのようなものですか？
- 2020年から2032年の間に、業界はどのように進化していくのでしょうか？現在および今後10年間に実施される精密がん診断検査プロジェクトにはどのような意味があるのか？
- 精密がん診断検査市場をさらに拡大するために、製品の商業化の必要性は高いか？
- 精密がん診断検査市場はどこに向かい、どのようにすれば市場の最前線に立つことができるか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の精密がん診断検査市場にどのような影響を与えるかを知る必要があります。
- 602ページにわたる本レポートでは、347の表と326のグラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、精密がん診断検査市場が今後10年間にどのように発展していくのか、またCOVID-19の景気後退や景気回復の変動に伴ってどのように変化していくのかをお伝えしています。この市場は、過去10年間のどの時点よりも今が重要である。

本レポートでは、貴社独自のCOVID-19のバリエーションと経済データをお届けします。

2032年までの予測やその他の分析により、商業的な展望が明らかになる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場ダイナミクス、ドライバー、機会、阻害要因、課題など）、コスト構造、精密がん診断検査価格上昇の影響、最近の動向などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

本レポートでカバーしているセグメント

生検方法
- ティシューバイオプシー
- リキッドバイオプシー

エンドユーザー
- 病院
- クリニック
- 研究機関

カテゴリー
- がん画像診断
- がん分子生物学的検査
- 腫瘍マーカーイムノアッセイ
- POC大腸がん検査
- その他のカテゴリー

がんタイプ
- 乳がん
- 肺がん
- 大腸がん
- メラノーマ
- 膵臓がん
- その他のかん

がん検診
- 血液型別分子生物学的がん検査
- HPVジェノタイピング
- 循環腫瘍細胞(CTC)検査
- 次世代シークエンス検査

画像検査
- コンピュータ断層撮影
- 磁気共鳴画像
- デジタル・アナログマンモグラフィ
- 陽電子放射断層撮影装置
- デジタルブレストトモシンセシス
- 乳房分子イメージング

世界市場全体およびセグメントの収益予測に加え、4地域および20の主要国市場の収益予測も掲載しています。

北米

- 米国
- カナダ
- メキシコ

欧州
- ドイツ
- スペイン
- イギリス
- フランス
- イタリア
- その他の欧州地域

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 南朝鮮
- その他のアジア太平洋地域

LAMEA
- ブラジル
- トルコ
- サウジアラビア
- 南アフリカ
- UAE
- 中南米、中東、アフリカのその他の地域

精密がん診断検査市場の主要企業のプロファイルと2022年から2032年まで、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。

主要企業と市場成長の可能性
・ Abbott Laboratories (Abbott)
・ Agilent Technologies, Inc.
・ AstraZeneca PLC (AstraZeneca)
・ Becton, Dickinson and Firm (BD)
・ Biocept, Inc.
・ Bio-Rad Laboratories Inc.
・ Epigenomics AG
・ Illumina, Inc. (Illumina)
・ Myriad Genetics, Inc. (Myriad)
・ Quest Diagnostics Incorporated

精密がん診断検査市場の世界全体の収益、2022年から2032年まで金額ベースで2022年に158億3400万米ドルを突破すると、当研究所は算出しています。2032年まで力強い収益成長が予測される。本調査では、最も大きな可能性を秘めた企業を特定します。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

精密がん診断検査市場、2022年から2032年までの市場レポートはどのように役立つのでしょうか？
602ページにわたるレポートをまとめると、以下のような知見が得られます。

- 精密がん診断検査市場の2032年までの収益予測、生検方法、エンドユーザー、がんタイプ、カテゴリー、分子がん検査をそれぞれ世界と地域レベルで予測-業界の展望を発見し、投資と収益に最も有利な場所を見出す

- 4つの地域と20の主要国市場の2032年までの収益予測 - 精密がん診断検査市場の2022年から2032年までの北米、欧州、アジア太平洋、LAMEAの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 精密がん診断検査市場に関わる主要企業10社の企業プロファイルを含む、既存企業および市場参入を目指す企業にとっての展望

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、精密がん診断テスト市場、2022年から2032年と大手企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1 レポートの概要
1.1 精密がん診断検査市場の紹介
1.2 世界の精密がん診断検査市場の概要
1.3 本レポートの目的とは？
1.4 レポートのスコープとは？
1.5 精密がん診断検査市場の定義
1.6 本レポートを読むべき理由
1.7 本レポートが提供するもの
1.8 本分析レポートが回答する主な質問には以下が含まれます。
1.9 本レポートは誰のためのものなのか？
1.10 調査方法
1.10.1 一次調査
1.10.2 セカンダリーリサーチ
1.10.3 市場評価・予測手法
1.11 よくある質問と回答（FAQ）
1.12 関連するVisiongainのレポート
1.13 Visiongainについて

2 エグゼクティブサマリー

3 グローバル市場のダイナミクス
3.1 市場のドライビングファクター
3.1.1 新興のFPMモデルおよびテクノロジー
3.1.2 従来のアプローチからNGS技術への置き換えが急速に進む
3.1.3 精密がん医療の裾野の広がり
3.2 市場の抑制要因
3.2.1 がんプレシジョン医療のデメリットと限界
3.2.2 がんプレシジョンメディシンのコスト
3.2.3 基礎的な遺伝子データを臨床的に適切で効果的な結論に変換することの難しさ
3.3 世界市場における機会
3.3.1 充実した治験の機会
3.3.2 FDAによって承認されたコンパニオン分子診断アッセイの数は増加している
3.3.3 診断・治療データと人工知能・機械学習プラットフォームとの統合
3.3.4 CDxは重要な機能を果たすことができる
3.4 世界市場における課題
3.4.1 遺伝子変化の検査とその後の標的治療にかかる費用
3.4.2 精密医療の臨床腫瘍学業務への取り込みが遅れている
3.4.3 プレシジョン・メディシンのエビデンス開発に関する技術的な難しさ
3.5 SWOT分析
3.6 PEST分析
3.6.1 政治的
3.6.2 経済的
3.6.3 社会的
3.6.4 技術的
3.7 ポーターズ分析
3.7.1 競争相手との競合
3.7.2 サプライヤーのバーゲニングパワー
3.7.3 顧客のバーゲニングパワー
3.7.4 新規参入の脅威
3.7.5 代替品の脅威

4 世界の精密がん診断検査市場分析
4.1 世界市場の展望
4.2 世界市場規模の推計と予測
4.2.1 COVID-19前の市場シナリオ
4.2.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）

5 世界の精密がん診断検査市場分析：地域別
5.1 北米
5.2 欧州
5.3 アジア太平洋
5.4 ラメア
5.5 地域別市場規模の推計と予測
5.5.1 COVID-19前の市場シナリオ
5.5.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）

6 世界の市場規模推定と予測：生検方法別
6.1 ティッシュバイオプシー
6.2 リキッドバイオプシー
6.3 COVID-19前の市場シナリオ
6.4 ポストCOVID-19の市場シナリオ（V、W、U、L字回復分析）

7 世界の市場規模推定と予測：エンドユーザー別
7.1 病院
7.2 クリニック
7.3 研究機関
7.4 COVID-19前の市場シナリオ
7.5 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）

8 世界の市場規模推定と予測：カテゴリー別
8.1 がん画像診断
8.2 がん分子生物学的検査
8.3 腫瘍マーカーイムノアッセイ
8.4 POC大腸がん検査
8.5 その他
8.6 COVID-19前の市場シナリオ
8.7 ポストCOVID-19の市場シナリオ（V、W、U、L字回復分析）

9 世界の市場規模推定と予測：がんタイプ別
9.1 乳がん
9.2 肺がん
9.3 大腸がん
9.4 メラノーマ
9.5 膵臓癌
9.6 その他のがん種
9.7 COVID-19前の市場シナリオ
9.8 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）

10 世界の市場規模推定と予測：分子がん検査別
10.1 血液検査によるがん分子生物学的検査
10.2 HPVジェノタイピング
10.3 血中循環腫瘍細胞（CTC）検査
10.4 次世代シークエンス検査
10.5 COVID-19前の市場シナリオ
10.6 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）

11 世界の市場規模推定と予測：がん画像検査別
11.1 コンピュータ断層撮影
11.2 磁気共鳴画像
11.3 デジタル＆アナログマンモグラフィ
11.4 陽電子放射断層撮影法
11.5 デジタルブレストトモシンセシス
11.6 分子乳房画像診断
11.7 COVID-19前の市場シナリオ
11.8 ポストCOVID-19の市場シナリオ（V、W、U、L字回復分析）

12 北米の市場規模推定と予測
12.1 市場の展望
12.2 北米市場規模の推定と予測
12.2.1 COVID-19前の市場シナリオ
12.2.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
12.3 国別市場規模の推定と予測
12.3.1 COVID-19前の市場シナリオ
12.3.2 COVID-19後の市場シナリオ（V、W、U、L字回復の分析）
12.4 北米生検方法別市場規模予測・予想
12.4.1 COVID-19前市場シナリオ
12.4.2 COVID-19後の市場シナリオ（V、W、U、L字回復分析）
12.5 北米のエンドユーザー別市場規模推定・予測
12.5.1 COVID-19前の市場シナリオ
12.5.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
12.6 北米のカテゴリー別市場規模推定・予測
12.6.1 COVID-19前の市場シナリオ
12.6.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
12.7 北米がんタイプ別市場規模推定・予測
12.7.1 COVID-19前市場シナリオ
12.7.2 COVID-19後の市場シナリオ（V、W、U、L字回復の分析）
12.8 北米における分子癌検査別市場規模の推定と予測
12.8.1 COVID-19前の市場シナリオ
12.8.2 COVID-19後の市場シナリオ（V、W、U、L字回復分析）
12.9 北米のがん画像検査別市場規模の推定と予測
12.9.1 COVID-19前の市場シナリオ
12.9.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
12.10 米国精密がん診断検査市場分析
12.10.1 米国におけるプレシジョンメディシン臨床試験数の増加
12.10.2 COVID-19前の市場シナリオ
12.10.3 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
12.11 カナダ精密がん診断検査市場分析
12.11.1 カナダにおける新しい全身性がん治療薬の採用は多段階プロセスである
12.11.2 カナダにおけるプレシジョン・メディシンの利用は癌のコントロールを助けるだろう
12.11.3 COVID-19前の市場シナリオ
12.11.4 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）
12.12 メキシコ精密がん診断検査市場分析
12.12.1 メキシコにおける政府機関・団体と連携した成功する長期的なプレシジョンオンコロジープログラムの開発
12.12.2 COVID-19前の市場シナリオ
12.12.3 ポストCOVID-19の市場シナリオ（V、W、U、L字回復分析）

13 欧州の市場規模推定と予測
13.1 市場の展望
13.2 欧州市場規模の推定と予測
13.2.1 COVID-19前の市場シナリオ
13.2.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
13.3 国別市場規模の推定と予測
13.3.1 COVID-19前の市場シナリオ
13.3.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.4 生検方法別欧州市場規模推定・予測
13.4.1 COVID-19前の市場シナリオ
13.4.2 COVID-19後の市場シナリオ（V、W、U、L字回復分析）
13.5 欧州のエンドユーザー別市場規模推定・予測
13.5.1 COVID-19前の市場シナリオ
13.5.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.6 欧州のカテゴリー別市場規模の推定と予測
13.6.1 COVID-19前の市場シナリオ
13.6.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.7 欧州のがんタイプ別市場規模推定・予測
13.7.1 COVID-19前の市場シナリオ
13.7.2 COVID-19後の市場シナリオ（V、W、U、L字回復の分析）
13.8 がん分子検査による欧州市場規模の推定と予測
13.8.1 COVID-19前の市場シナリオ
13.8.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.9 がん画像検査による欧州市場規模の推定と予測
13.9.1 COVID-19前の市場シナリオ
13.9.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.10 ドイツ精密がん診断検査市場分析
13.10.1 ドイツにおける学際的手法の急速な統合
13.10.2 COVID-19前の市場シナリオ
13.10.3 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
13.11 英国精密がん診断検査市場分析
13.11.1 英国におけるクリニカルトレイル研究の拡大
13.11.2 膵臓がん研究への投資
13.11.3 COVID-19前の市場シナリオ
13.11.4 ポストCOVID-19市場シナリオ（V、W、U、L字型回復分析）
13.12 フランス精密がん診断検査市場分析
13.12.1 COVID-19前の市場シナリオ
13.12.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
13.13 イタリア精密がん診断検査市場分析
13.13.1 イタリアにおけるプレシジョンオンコロジーの拡大はガイドラインの欠如によって阻害されている
13.13.2 COVID-19前の市場シナリオ
13.13.3 ポストCOVID-19の市場シナリオ（V、W、U、L字回復分析）
13.14 スペイン精密がん診断検査市場分析
13.14.1 スペインでは現在、はるかに多くの変異を検出することに精密がん診断検査研究の焦点が当てられている
13.14.2 COVID-19前の市場シナリオ
13.14.3 ポストCOVID-19市場シナリオ（V、W、U、L字型回復分析）
13.15 その他の欧州の精密がん診断検査市場分析
13.15.1 COVID-19前の市場シナリオ
13.15.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）

14 アジア太平洋地域の市場規模推計と予測
14.1 市場の展望
14.2 アジア太平洋地域の市場規模推計と予測
14.2.1 COVID-19前の市場シナリオ
14.2.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
14.3 国別市場規模の推定と予測
14.3.1 COVID-19前の市場シナリオ
14.3.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
14.4 アジア太平洋地域の生検方法別市場規模推定・予測
14.4.1 COVID-19前の市場シナリオ
14.4.2 COVID-19後の市場シナリオ（V、W、U、L字回復分析）
14.5 アジア太平洋地域のエンドユーザー別市場規模の推定と予測
14.5.1 COVID-19前の市場シナリオ
14.5.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
14.6 アジア太平洋地域のカテゴリー別市場規模の推定と予測
14.6.1 COVID-19前の市場シナリオ
14.6.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
14.7 アジア太平洋地域の癌タイプ別市場規模推定・予測
14.7.1 COVID-19前市場シナリオ
14.7.2 COVID-19後の市場シナリオ（V、W、U、L字回復の分析）
14.8 アジア太平洋地域のがん分子検査市場規模予測・予測：がん分子検査別
14.8.1 COVID-19前の市場シナリオ
14.8.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
14.9 アジア太平洋地域の癌画像検査別市場規模の推定と予測
14.9.1 COVID-19前の市場シナリオ
14.9.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
14.10 中国精密がん診断検査市場分析
14.10.1 自己発電型トライボエレクトリック・ナノジェネレータ（TENG）デバイスの大規模展開が癌治療に期待される
14.10.2 COVID-19前の市場シナリオ
14.10.3 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）
14.11 インド精密がん診断検査市場分析
14.11.1 COVID-19前の市場シナリオ
14.11.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
14.12 日本の精密がん診断検査市場分析
14.12.1 プレシジョンオンコロジーは日本のがん患者治療に革命をもたらすが、多くの病院がその実践に苦労している
14.12.2 COVID-19前の市場シナリオ
14.12.3 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）
14.13 韓国精密がん診断検査市場分析
14.13.1 韓国では様々なプレシジョンメディスン共同研究が行われている
14.13.2 COVID-19前の市場シナリオ
14.13.3 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
14.14 オーストラリア精密がん診断検査市場分析
14.14.1 COVID-19前の市場シナリオ
14.14.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
14.15 その他のアジア太平洋地域の精密がん診断検査市場分析
14.15.1 COVID-19前の市場シナリオ
14.15.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）

15 LAMEAの市場規模の推定と予測
15.1 市場の展望
15.2 LAMEAの市場規模推定と予測
15.2.1 COVID-19前の市場シナリオ
15.2.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
15.3 国別市場規模の推定と予測
15.3.1 COVID-19前の市場シナリオ
15.3.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.4 LAMEA生検方法別市場規模推定・予測
15.4.1 COVID-19前の市場シナリオ
15.4.2 COVID-19後の市場シナリオ（V、W、U、L字回復分析）
15.5 LAMEAのエンドユーザー別市場規模の推定と予測
15.5.1 COVID-19前の市場シナリオ
15.5.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.6 LAMEAのカテゴリー別市場規模の推定と予測
15.6.1 COVID-19前の市場シナリオ
15.6.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.7 LAMEAのがんタイプ別市場規模予測・予想
15.7.1 COVID-19前の市場シナリオ
15.7.2 COVID-19後の市場シナリオ（V、W、U、L字回復の分析）
15.8 LAMEA 分子癌検査市場規模予測・予測：分子癌検査別
15.8.1 COVID-19前の市場シナリオ
15.8.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.9 LAMEAのがん画像検査別市場規模推定・予測
15.9.1 COVID-19前の市場シナリオ
15.9.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.10 ブラジル精密がん診断検査市場分析
15.10.1 ブラジルはがん研究に多大な貢献をしている
15.10.2 ブラジルは精密医療の潜在的利益という点で、他の中南米諸国のモデルになりやすい
15.10.3 COVID-19前の市場シナリオ
15.10.4 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）
15.11 南アフリカの精密がん診断検査市場分析
15.11.1 精密医療を発展させるためには、南アフリカでより多くの専門家が必要となる
15.11.2 COVID-19前の市場シナリオ
15.11.3 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
15.12 サウジアラビアの精密がん診断検査市場分析
15.12.1 精密がん診断検査はサウジアラビアのがん診断・治療環境に大きな変革をもたらした
15.12.2 COVID-19前の市場シナリオ
15.12.3 ポストCOVID-19の市場シナリオ（V、W、U、L字型回復分析）
15.13 トルコ精密がん診断検査市場分析
15.13.1 COVID-19前の市場シナリオ
15.13.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.14 UAEの精密がん診断検査市場分析
15.14.1 精密がん診断テスト増加のために新たなコラボレーション戦略を活用するUAEの企業
15.14.2 COVID-19前の市場シナリオ
15.14.3 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
15.15 LAMEAのその他の地域の精密がん診断検査市場分析
15.15.1 COVID-19前の市場シナリオ
15.15.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）

16 主要企業のプロフィール
16.1 バイオ・ラッド・ラボラトリーズ・インク
16.1.1 企業スナップショット
16.1.2 会社概要
16.1.3 会社の財務状況
16.1.4 会社の製品ベンチマーク
16.1.5 会社の最近の動向
16.2 イルミナ社
16.2.1 企業スナップショット
16.2.2 会社概要
16.2.3 会社の財務プロファイル
16.2.4 会社の製品ベンチマーク
16.2.5 会社の最近の動向
16.3 バイオセプト社
16.3.1 会社概要
16.3.2 会社概要
16.3.3 財務概要
16.3.4 当社の製品ベンチマーク
16.3.5 会社の最近の動き
16.4 エピゲノミクス社
16.4.1 会社概要
16.4.2 会社概要
16.4.3 財務プロファイル
16.4.4 会社の製品ベンチマーク
16.5 アストラゼネカ plc
16.5.1 企業スナップショット
16.5.2 会社概要
16.5.3 財務プロファイル
16.5.4 会社の製品ベンチマーク
16.5.5 会社の最近の開発
16.6 ミリアド・ジェネティクス
16.6.1 企業スナップショット
16.6.2 会社概要
16.6.3 ベンチマーキング製品
16.6.4 会社の最近の開発
16.7 クエスト・ダイアグノスティックス
16.7.1 企業スナップショット
16.7.2 会社概要
16.7.3 財務プロファイル
16.7.4 会社の製品ベンチマーク
16.7.5 会社の最近の動向
16.8 アボット・ラボラトリーズ
16.8.1 会社概要
16.8.2 会社概要
16.8.3 財務概要
16.8.4 当社の製品ベンチマーク
16.8.5 会社の最近の開発状況
16.9 アジレント・テクノロジー
16.9.1 企業スナップショット
16.9.2 会社概要
16.9.3 財務概要
16.9.4 会社の製品ベンチマーク
16.9.5 会社の最近の開発状況
16.10 ベクトン・ディッキンソン社
16.10.1 企業スナップショット
16.10.2 会社概要
16.10.3 財務概要
16.10.4 会社の製品ベンチマーク
16.10.5 会社の最近の動向

17 結論と提言
17.1 結論
17.2 提言

表の一覧
Figure 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Precision Cancer Diagnostic Test Market Segmentation
Figure 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 4 SWOT Analysis
Figure 5 PEST Analysis
Figure 6 Porters Five Forces
Figure 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 8 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 9 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 10 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 11 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 12 Global Precision Cancer Diagnostic Test Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 13 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 14 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 15 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 16 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 17 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 18 Global Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method 2022, 2027, 2032 (%)
Figure 19 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 20 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 21 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 22 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 23 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 24 Global Precision Cancer Diagnostic Test Market Share Forecast by End-User 2022, 2027, 2032 (%)
Figure 25 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Precision Cancer Diagnostic Test Market Share Forecast by Category 2022, 2027, 2032 (%)
Figure 31 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 32 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 33 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 34 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 35 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 36 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Type 2022, 2027, 2032 (%)
Figure 37 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 38 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 39 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 40 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 41 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 42 Global Precision Cancer Diagnostic Test Market Share Forecast by Molecular Cancer Testing 2022, 2027, 2032 (%)
Figure 43 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 44 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 45 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 46 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 47 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 48 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Imaging Test 2022, 2027, 2032 (%)
Figure 49 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 50 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 51 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 52 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 53 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 54 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 55 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 56 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 57 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 58 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 59 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%))
Figure 60 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (V-Shaped Recovery Scenario)
Figure 61 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (W-Shaped Recovery Scenario)
Figure 62 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (U-Shaped Recovery Scenario)
Figure 63 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (L-Shaped Recovery Scenario)
Figure 64 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 65 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 66 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 67 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 68 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 69 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 70 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 71 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 72 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 73 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 74 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 75 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 76 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 77 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 78 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 79 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 80 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 81 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 82 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 83 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 84 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 85 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 86 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 87 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 88 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 89 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 90 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 95 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 96 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 97 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 98 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 99 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 100 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 101 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 102 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 103 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 104 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 105 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 106 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 107 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 108 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 109 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 110 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 111 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 112 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 113 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 114 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 115 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 116 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 117 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 118 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 119 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 120 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 121 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 122 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 123 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 124 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 125 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 126 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 127 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 128 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 129 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 130 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 131 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 132 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 133 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 134 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 135 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 136 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 137 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 138 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 139 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 140 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 141 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 142 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 143 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 144 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 145 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 146 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 147 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 148 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 149 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 151 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 152 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 153 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 154 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 156 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 157 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 158 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 159 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 161 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 162 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 163 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 164 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 165 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 166 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 167 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 168 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 169 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 170 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 171 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 172 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 173 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 174 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 175 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 176 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 177 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 178 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 195 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 196 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 200 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 201 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 202 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 203 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 204 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 205 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 206 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 207 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 208 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 209 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 210 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 211 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 212 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 213 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 214 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 215 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 216 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 217 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 218 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 219 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 220 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 221 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 222 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 223 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 224 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 225 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 226 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 227 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 228 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 229 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 230 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 231 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 232 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 233 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 234 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 235 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 236 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 237 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 238 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 239 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 240 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 241 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 242 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 243 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 244 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 245 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 246 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 247 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 248 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 249 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 250 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 251 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 252 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 253 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 254 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 255 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 256 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 257 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 258 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 259 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 260 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 261 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 262 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 263 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 264 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 265 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 266 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 267 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 268 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 269 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 270 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 271 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 272 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 273 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 274 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 275 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 276 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 277 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 278 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 279 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 280 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 281 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 282 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 283 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 284 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 285 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 286 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 287 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 288 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 289 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 291 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 292 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 293 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 294 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 295 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 296 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 297 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 298 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 299 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 300 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 301 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 302 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 303 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 304 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 305 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 306 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 307 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 308 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 309 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 310 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 311 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 312 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 313 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 314 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 315 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 316 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 317 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 318 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 319 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 320 Bio-Rad Laboratories Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 321 Bio-Rad Laboratories Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 322 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 323 Illumina Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 324 Illumina Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 325 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 326 Biocept Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 327 Biocept Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 328 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 329 Epigenomics AG: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 330 Epigenomics AG: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 331 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 332 AstraZeneca Plc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 333 AstraZeneca Plc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 334 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 335 Quest Diagnostics Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 336 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 337 Abbott Laboratories: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 338 Abbott Laboratories: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 339 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 340 Agilent Technologies Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 341 Agilent Technologies Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 342 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 343 Becton Dickinson and Co: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 344 Becton Dickinson and Co: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)

図の一覧
Table 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 2 Global Precision Cancer Diagnostic Test Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 4 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 5 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 6 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 8 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 9 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 10 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 11 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 12 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 13 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 14 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 15 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 16 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 17 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 18 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 19 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 20 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 21 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 22 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 23 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 24 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 25 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 26 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 27 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 28 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 29 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 30 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 31 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 32 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 33 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 34 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 35 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 36 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 37 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 38 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 40 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 41 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 42 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 43 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 44 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 45 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 46 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 47 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 48 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 49 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 50 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 51 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 52 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 53 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 54 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 55 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 56 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 57 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 58 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 59 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 60 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 61 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 62 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 63 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 65 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 66 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 67 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 68 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 69 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 70 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 71 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 72 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 73 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 74 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 75 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 76 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 77 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 78 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 79 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 80 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 81 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 82 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 83 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 84 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 85 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 86 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 87 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 88 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 89 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 90 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 91 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 92 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 93 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 94 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 95 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 96 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 97 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 98 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 99 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 100 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 101 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 102 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 103 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 104 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 105 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 106 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 107 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 108 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 109 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 110 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 111 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 112 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 113 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 114 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 115 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 116 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 117 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 118 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 119 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 120 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 121 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 122 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 123 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 124 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 125 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 126 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 127 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 128 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 129 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 130 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 131 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 132 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 133 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 134 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 135 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 136 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 137 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 138 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 139 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 140 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 141 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 142 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 143 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 144 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 145 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 146 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 147 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 148 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 149 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 150 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 151 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 152 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 153 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 154 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 155 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 156 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 157 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 158 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 159 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 160 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 161 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 162 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 163 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 164 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 165 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 166 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 167 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 168 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 169 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 170 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 171 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 172 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 173 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 174 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 175 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 176 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 177 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 178 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 193 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 194 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 195 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 196 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 197 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 198 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 199 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 200 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 201 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 202 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 203 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 204 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 205 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 206 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 207 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 208 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 209 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 210 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 211 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 212 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 213 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 214 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 215 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 216 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 217 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 218 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 219 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 220 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 221 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 222 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 223 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 224 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 225 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 226 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 227 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 228 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 229 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 230 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 231 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 232 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 233 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 234 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 235 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 236 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 237 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 238 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 239 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 240 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 241 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 242 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))) (L-Shaped Recovery Scenario)
Table 243 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 244 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 245 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 246 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 247 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 248 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 249 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 250 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 251 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 252 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 253 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 254 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 255 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 256 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 257 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 258 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 259 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 260 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 261 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 262 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 263 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 264 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 265 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 266 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 267 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 268 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 269 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 270 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 271 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 272 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 273 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 274 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 275 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 276 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 277 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 278 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 279 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 280 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 281 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 282 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 283 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 284 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 285 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 286 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 287 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 288 Bio-Rad Laboratories Inc.: Company Information
Table 289 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 290 Bio-Rad Laboratories Inc.: Company Product and Service Benchmarking
Table 291 Bio-Rad Laboratories Inc: Company Recent Developments
Table 292 Illumina Inc.: Company Information
Table 293 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 294 Illumina Inc.: Company Product and Service Benchmarking
Table 295 Illumina Inc: Company Recent Developments
Table 296 Biocept Inc.: Company Information
Table 297 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 298 Biocept Inc.: Company Product and Service Benchmarking
Table 299 Biocept Inc: Company Recent Developments
Table 300 Epigenomics A.: Company Information
Table 301 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 302 Epigenomics AG.: Company Product and Service Benchmarking
Table 303 AstraZeneca Plc.: Company Information
Table 304 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 305 AstraZeneca Plc.: Company Product and Service Benchmarking
Table 306 AstraZeneca Plc: Company Recent Developments
Table 307 Myriad Genetics Inc.: Company Information
Table 308 Myriad Genetics Inc.: Company Product and Service Benchmarking
Table 309 Myriad Genetics Inc: Company Recent Developments
Table 310 Quest Diagnostics Inc.: Company Information
Table 311 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 312 Quest Diagnostics Inc.: Company Product and Service Benchmarking
Table 313 Quest Diagnostics Inc: Company Recent Developments
Table 314 Abbott Laboratories.: Company Information
Table 315 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 316 Abbott Laboratories.: Company Product and Service Benchmarking
Table 317 Abbott Laboratories: Company Recent Developments
Table 318 Agilent Technologies Inc.: Company Information
Table 319 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 320 Agilent Technologies Inc: Company Product and Service Benchmarking
Table 321 Agilent Technologies Inc: Company Recent Developments
Table 322 Becton Dickinson and Co.: Company Information
Table 323 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 324 Becton Dickinson and Co.: Company Product and Service Benchmarking
Table 325 Becton Dickinson and Co: Company Recent Developments

ページTOPに戻る

Table of Contents

Summary

この調査レポートは世界の精密がん診断検査市場を調査し、生検方法別、エンドユーザー別、カテゴリー別、がんタイプ別、分子がん検査別、がん画像検査別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

レポート概要
エグゼクティブサマリー
世界市場のダイナミックス
世界の精密がん診断検査市場分析
世界の精密がん診断検査市場分析：地域別
世界の市場規模推定と予測：生検方法別
世界の市場規模推定と予測：エンドユーザー別
世界の市場規模推定と予測：カテゴリー別
世界の市場規模推定と予測：がんタイプ別
世界の市場規模推定と予測：分子がん検査別
世界の市場規模推定と予測：がん画像検査別
北米の市場規模推定と予測
欧州の市場規模推定と予測
アジア太平洋地域の市場規模推定と予測
LAMEAの市場規模推定と予測
主要企業のプロフィール

Report Details

The Precision Cancer Diagnostic Test Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Technologies such as Functional Precision Medicine (FPM) Models
Some of the practical challenges of FPM can be addressed using new technologies created at the intersection of engineering and biology. Technology targeted at simulating the tumour microenvironment, particularly the extracellular matrix, has made significant progress. Organ chips (sometimes referred to as tissue chips or microphysiological systems) are indeed being used to depict cancer inside the tumour microenvironment. Such microfluidics devices, which are typically composed of tissue-specific types of cells, extracellular matrix gels, and cancerous cells, attempt to replicate the molecular and mechanical signals present in human tissue. One of the possible advantages of organ chips is their ability to replicate medicine distribution, pharmacokinetics, pharmacodynamics, and drug toxicity.

Some of the hurdles to the broad use of organ chips in FPM include low drug testing throughput and the necessity for specialised skills to create and operate these devices. Allowing cells to remain in their native habitat throughout pharmaceutical therapy is another way to simulate tumour settings. This comprises medication treatment on individual tumour sections or fine-needle biopsies, wherein immunofluorescent cell death signs can be used to assess drug sensitivity. Its use of drug-containing microdevices which may be implanted directly into patients’ tumours is another promising approach for FPM. The medications in such microdevices can affect surrounding tissues, and therapy results in tumours can indeed be evaluated after they’ve been removed.

What Questions Should You Ask before Buying a Market Research Report?
• How is the precision cancer diagnostic test market evolving?
• What is driving and restraining the precision cancer diagnostic test market?
• How will each precision cancer diagnostic test submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each precision cancer diagnostic test submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading precision cancer diagnostic test markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the precision cancer diagnostic test projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implication of precision cancer diagnostic test projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the precision cancer diagnostic test market?
• Where is the precision cancer diagnostic test market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the precision cancer diagnostic test market today, and over the next 10 years:
• Our 602-page report provides 347 tables and 326 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analyse of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the precision cancer diagnostic test market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

This report delivers exclusive COVID-19 variations and economic data specific to your market.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision cancer diagnostic test prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in this report

Biopsy Method
• Tissue Biopsy
• Liquid Biopsy

End-User
• Hospitals
• Clinics
• Research Institutes

Category
• Cancer Imaging
• Molecular Cancer Testing
• Tumour Marker Immunoassays
• POC Colon Cancer Tests
• Other Categories

Cancer Type
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Pancreatic Cancer
• Other Cancer Type

Cancer Testing
• Blood-Based Molecular Cancer Tests
• HPV Genotyping
• Circulating Tumour Cell (CTC) Tests
• Next-Generation Sequencing Tests

Imaging Test
• Computed Tomography
• Magnetic Resonance Imaging
• Digital & Analog Mammography
• Positron Emission Tomography
• Digital Breast Tomosynthesis
• Molecular Breast Imaging

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada
• Mexico

Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America, Middle East and Africa

The report also includes profiles and for some of the leading companies in the Precision Cancer Diagnostic Test Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories (Abbott)
• Agilent Technologies, Inc.
• AstraZeneca PLC (AstraZeneca)
• Becton, Dickinson and Firm (BD)
• Biocept, Inc.
• Bio-Rad Laboratories Inc.
• Epigenomics AG
• Illumina, Inc. (Illumina)
• Myriad Genetics, Inc. (Myriad)
• Quest Diagnostics Incorporated

Overall world revenue for Precision Cancer Diagnostic Test Market, 2022 to 2032 in terms of value the market will surpass US$15,834 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Precision Cancer Diagnostic Test Market, 2022 to 2032 Market report help you?
In summary, our 602-page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Precision Cancer Diagnostic Test Market, 2022 to 2032 Market, with forecasts for biopsy method, end-user, cancer type, category, molecular cancer testing each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Precision Cancer Diagnostic Test Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Precision Cancer Diagnostic Test Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analysis for the Precision Cancer Diagnostic Test Market, 2022 to 2032 and leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Introduction to Precision Cancer Diagnostic Test Market
1.2 Global Precision Cancer Diagnostic Test Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Precision Cancer Diagnostic Test Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain

2 Executive Summary

3 Global Market Dynamics
3.1 Market Driving Factors
3.1.1 Emerging FPM Models and Technologies
3.1.2 NGS Technologies Are Rapidly Being Used in Place of Traditional Approaches
3.1.3 Precision Cancer Medicine's Expanding Breadth
3.2 Market Restraining Factors
3.2.1 Disadvantages and Limitations of Precision Medicine in Cancer
3.2.2 Cost of Cancer Precision Medicine
3.2.3 Difficulty of Converting Basic Genetic Data into Clinically Relevant and Effective Conclusions
3.3 Opportunities in the Global Market
3.3.1 Enhanced Trial Opportunities
3.3.2 Number of Companion Molecular Diagnostic Assays Approved by the FDA is Increasing
3.3.3 Integration of Diagnostic and Treatment Data with Emerging Artificial Intelligence/Machine Learning Platforms
3.3.4 CDx Can Play an Important Function
3.4 Challenges in the Global Market
3.4.1 Expense of Testing for Genetic Changes and Subsequent Targeted Therapy
3.4.2 Precision Medicine's Incorporation into Clinical Oncology Operations Has Been Delayed
3.4.3 Technical Difficulties Related with the Development of Precision Medicine’s Evidence
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Porters Analysis
3.7.1 Competitive Rivalry
3.7.2 Bargaining Power of Suppliers
3.7.3 Bargaining Power of Customers
3.7.4 Threat of New Entrants
3.7.5 Threat of Substitutes

4 Global Precision Cancer Diagnostic Test Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

5 Global Precision Cancer Diagnostic Test Market Analysis by Region
5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Market Size Estimation and Forecast by Biopsy Method
6.1 Tissue Biopsy
6.2 Liquid Biopsy
6.3 Pre-COVID-19 Market Scenario
6.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Market Size Estimation and Forecast by End-User
7.1 Hospitals
7.2 Clinics
7.3 Research Institutes
7.4 Pre-COVID-19 Market Scenario
7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Market Size Estimation and Forecast by Category
8.1 Cancer Imaging
8.2 Molecular Cancer Testing
8.3 Tumour Marker Immunoassays
8.4 POC Colon Cancer Tests
8.5 Others
8.6 Pre-COVID-19 Market Scenario
8.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Market Size Estimation and Forecast by Cancer Type
9.1 Breast Cancer
9.2 Lung Cancer
9.3 Colorectal Cancer
9.4 Melanoma
9.5 Pancreatic Cancer
9.6 Other Cancer Types
9.7 Pre-COVID-19 Market Scenario
9.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Market Size Estimation and Forecast by Molecular Cancer Testing
10.1 Blood-Based Molecular Cancer Tests
10.2 HPV Genotyping
10.3 Circulating Tumour Cell (CTC) Tests
10.4 Next-Generation Sequencing Tests
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Market Size Estimation and Forecast by Cancer Imaging Test
11.1 Computed Tomography
11.2 Magnetic Resonance Imaging
11.3 Digital & Analog Mammography
11.4 Positron Emission Tomography
11.5 Digital Breast Tomosynthesis
11.6 Molecular Breast Imaging
11.7 Pre-COVID-19 Market Scenario
11.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 North America Market Size Estimation and Forecast
12.1 Market Outlook
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast by Biopsy Method
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by End-User
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Category
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast by Cancer Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast by Molecular Cancer Testing
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast by Cancer Imaging Test
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Precision Cancer Diagnostic Test Market Analysis
12.10.1 Increasing Number of Precision Medicine Clinical Trials in the United States
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Precision Cancer Diagnostic Test Market Analysis
12.11.1 Adoption of New Systemic Cancer Medicines in Canada is a Multi-Step Process
12.11.2 The Use of Precision Medicine in Canada Will Aid in the Control of Cancer
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Precision Cancer Diagnostic Test Market Analysis
12.12.1 Developing Successful and Long-Term Precision Oncology Programmes in Mexico in Collaboration with Government Authorities and Institutions
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 Europe Market Size Estimation and Forecast
13.1 Market Outlook
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast by Biopsy Method
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast by End-User
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Category
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Cancer Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast by Molecular Cancer Testing
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast by Cancer Imaging Test
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Germany Precision Cancer Diagnostic Test Market Analysis
13.10.1 Rapid Integration of Interdisciplinary Techniques in Germany
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UK Precision Cancer Diagnostic Test Market Analysis
13.11.1 Expanding Clinical Trails Studies in UK
13.11.2 Investment in Pancreatic Cancer Research
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 France Precision Cancer Diagnostic Test Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Italy Precision Cancer Diagnostic Test Market Analysis
13.13.1 The Expansion of Precision Oncology in Italy Has Been Impeded by a Lack of Guidelines
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Spain Precision Cancer Diagnostic Test Market Analysis
13.14.1 Precision Cancer Diagnostic Test Research is Now Focusing on Detecting a Far Larger Number of Mutations in Spain
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Rest of Europe Precision Cancer Diagnostic Test Market Analysis
13.15.1 Pre-COVID-19 Market Scenario
13.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Asia-Pacific Market Size Estimation and Forecast
14.1 Market Outlook
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast by Biopsy Method
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast by End-User
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Category
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Cancer Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Molecular Cancer Testing
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast by Cancer Imaging Test
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Precision Cancer Diagnostic Test Market Analysis
14.10.1 Large-Scale Deployment of Self-Powered Triboelectric Nanogenerator (TENG) Devices Has Promise for Cancer Treatment
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Precision Cancer Diagnostic Test Market Analysis
14.11.1 Pre-COVID-19 Market Scenario
14.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Precision Cancer Diagnostic Test Market Analysis
14.12.1 Precision Oncology Is Revolutionising Cancer Patient Treatment in Japan, but Many Hospitals Are Having Trouble Putting it into Practise
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Precision Cancer Diagnostic Test Market Analysis
14.13.1 Various Precision Medicine Collaborations Are Taking Place in South Korea
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Precision Cancer Diagnostic Test Market Analysis
14.14.1 Pre-COVID-19 Market Scenario
14.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 LAMEA Market Size Estimation and Forecast
15.1 Market Outlook
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Country Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast by Biopsy Method
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast by End-User
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Category
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Cancer Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast by Molecular Cancer Testing
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast by Cancer Imaging Test
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Brazil Precision Cancer Diagnostic Test Market Analysis
15.10.1 Brazil is Making Significant Contributions to Cancer Research
15.10.2 Brazil Can Easily Become a Model for Other Latin American Countries, in Terms of the Potential Benefits of Precision Medicine
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 South Africa Precision Cancer Diagnostic Test Market Analysis
15.11.1 To Develop Precision Medicine Requires More Specialised Professionals in South Africa
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 Saudi Arabia Precision Cancer Diagnostic Test Market Analysis
15.12.1 Precision Cancer Diagnostic Test Has Significantly Revolutionised the Cancer Diagnostic and Treatment Environment in Saudi Arabia
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Turkey Precision Cancer Diagnostic Test Market Analysis
15.13.1 Pre-COVID-19 Market Scenario
15.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 UAE Precision Cancer Diagnostic Test Market Analysis
15.14.1 Companies in the UAE Utilising New Collaboration Strategies to Increase Precision Cancer Diagnostic Test
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 Rest of LAMEA Precision Cancer Diagnostic Test Market Analysis
15.15.1 Pre-COVID-19 Market Scenario
15.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 Company Profiles
16.1 Bio-Rad Laboratories Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.1.5 Company Recent Developments
16.2 Illumina Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Biocept Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 Epigenomics AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.5 AstraZeneca plc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product Benchmarking
16.5.5 Company Recent Developments
16.6 Myriad Genetics Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.6.4 Company Recent Developments
16.7 Quest Diagnostics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Abbott Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product Benchmarking
16.8.5 Company Recent Developments
16.9 Agilent Technologies Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Becton Dickinson and Co.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.4 Company Product Benchmarking
16.10.5 Company Recent Developments

17 Conclusion and Recommendations
17.1 Conclusion Summary
17.2 Recommendations

List of Figures
Figure 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Precision Cancer Diagnostic Test Market Segmentation
Figure 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 4 SWOT Analysis
Figure 5 PEST Analysis
Figure 6 Porters Five Forces
Figure 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 8 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 9 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 10 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 11 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 12 Global Precision Cancer Diagnostic Test Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 13 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 14 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 15 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 16 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 17 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 18 Global Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method 2022, 2027, 2032 (%)
Figure 19 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 20 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 21 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 22 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 23 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 24 Global Precision Cancer Diagnostic Test Market Share Forecast by End-User 2022, 2027, 2032 (%)
Figure 25 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Precision Cancer Diagnostic Test Market Share Forecast by Category 2022, 2027, 2032 (%)
Figure 31 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 32 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 33 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 34 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 35 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 36 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Type 2022, 2027, 2032 (%)
Figure 37 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 38 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 39 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 40 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 41 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 42 Global Precision Cancer Diagnostic Test Market Share Forecast by Molecular Cancer Testing 2022, 2027, 2032 (%)
Figure 43 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 44 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 45 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 46 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 47 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 48 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Imaging Test 2022, 2027, 2032 (%)
Figure 49 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 50 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 51 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 52 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 53 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 54 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 55 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 56 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 57 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 58 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 59 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%))
Figure 60 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (V-Shaped Recovery Scenario)
Figure 61 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (W-Shaped Recovery Scenario)
Figure 62 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (U-Shaped Recovery Scenario)
Figure 63 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (L-Shaped Recovery Scenario)
Figure 64 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 65 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 66 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 67 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 68 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 69 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 70 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 71 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 72 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 73 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 74 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 75 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 76 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 77 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 78 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 79 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 80 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 81 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 82 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 83 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 84 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 85 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 86 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 87 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 88 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 89 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 90 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 95 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 96 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 97 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 98 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 99 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 100 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 101 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 102 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 103 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 104 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 105 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 106 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 107 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 108 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 109 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 110 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 111 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 112 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 113 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 114 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 115 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 116 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 117 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 118 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 119 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 120 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 121 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 122 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 123 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 124 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 125 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 126 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 127 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 128 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 129 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 130 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 131 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 132 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 133 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 134 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 135 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 136 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 137 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 138 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 139 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 140 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 141 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 142 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 143 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 144 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 145 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 146 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 147 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 148 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 149 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 151 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 152 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 153 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 154 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 156 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 157 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 158 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 159 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 161 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 162 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 163 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 164 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 165 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 166 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 167 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 168 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 169 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 170 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 171 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 172 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 173 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 174 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 175 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 176 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 177 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 178 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 195 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 196 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 200 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 201 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 202 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 203 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 204 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 205 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 206 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 207 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 208 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 209 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 210 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 211 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 212 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 213 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 214 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 215 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 216 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 217 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 218 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 219 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 220 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 221 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 222 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 223 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 224 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 225 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 226 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 227 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 228 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 229 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 230 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 231 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 232 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 233 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 234 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 235 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 236 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 237 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 238 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 239 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 240 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 241 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 242 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 243 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 244 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 245 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 246 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 247 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 248 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 249 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 250 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 251 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 252 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 253 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 254 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 255 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 256 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 257 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 258 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 259 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 260 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 261 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 262 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 263 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 264 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 265 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 266 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 267 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 268 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 269 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 270 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 271 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 272 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 273 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 274 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 275 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 276 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 277 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 278 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 279 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 280 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 281 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 282 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 283 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 284 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 285 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 286 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 287 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 288 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 289 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 291 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 292 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 293 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 294 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 295 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 296 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 297 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 298 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 299 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 300 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 301 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 302 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 303 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 304 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 305 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 306 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 307 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 308 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 309 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 310 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 311 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 312 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 313 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 314 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 315 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 316 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 317 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 318 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 319 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 320 Bio-Rad Laboratories Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 321 Bio-Rad Laboratories Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 322 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 323 Illumina Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 324 Illumina Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 325 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 326 Biocept Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 327 Biocept Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 328 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 329 Epigenomics AG: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 330 Epigenomics AG: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 331 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 332 AstraZeneca Plc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 333 AstraZeneca Plc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 334 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 335 Quest Diagnostics Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 336 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 337 Abbott Laboratories: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 338 Abbott Laboratories: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 339 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 340 Agilent Technologies Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 341 Agilent Technologies Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 342 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 343 Becton Dickinson and Co: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 344 Becton Dickinson and Co: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)

List of Tables
Table 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 2 Global Precision Cancer Diagnostic Test Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 4 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 5 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 6 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 8 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 9 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 10 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 11 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 12 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 13 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 14 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 15 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 16 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 17 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 18 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 19 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 20 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 21 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 22 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 23 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 24 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 25 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 26 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 27 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 28 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 29 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 30 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 31 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 32 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 33 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 34 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 35 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 36 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 37 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 38 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 40 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 41 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 42 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 43 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 44 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 45 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 46 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 47 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 48 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 49 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 50 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 51 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 52 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 53 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 54 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 55 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 56 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 57 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 58 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 59 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 60 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 61 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 62 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 63 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 65 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 66 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 67 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 68 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 69 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 70 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 71 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 72 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 73 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 74 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 75 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 76 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 77 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 78 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 79 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 80 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 81 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 82 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 83 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 84 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 85 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 86 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 87 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 88 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 89 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 90 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 91 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 92 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 93 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 94 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 95 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 96 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 97 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 98 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 99 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 100 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 101 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 102 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 103 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 104 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 105 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 106 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 107 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 108 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 109 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 110 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 111 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 112 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 113 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 114 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 115 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 116 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 117 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 118 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 119 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 120 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 121 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 122 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 123 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 124 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 125 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 126 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 127 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 128 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 129 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 130 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 131 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 132 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 133 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 134 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 135 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 136 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 137 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 138 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 139 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 140 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 141 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 142 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 143 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 144 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 145 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 146 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 147 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 148 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 149 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 150 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 151 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 152 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 153 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 154 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 155 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 156 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 157 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 158 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 159 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 160 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 161 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 162 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 163 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 164 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 165 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 166 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 167 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 168 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 169 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 170 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 171 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 172 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 173 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 174 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 175 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 176 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 177 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 178 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 193 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 194 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 195 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 196 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 197 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 198 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 199 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 200 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 201 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 202 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 203 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 204 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 205 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 206 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 207 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 208 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 209 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 210 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 211 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 212 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 213 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 214 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 215 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 216 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 217 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 218 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 219 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 220 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 221 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 222 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 223 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 224 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 225 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 226 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 227 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 228 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 229 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 230 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 231 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 232 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 233 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 234 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 235 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 236 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 237 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 238 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 239 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 240 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 241 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 242 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))) (L-Shaped Recovery Scenario)
Table 243 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 244 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 245 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 246 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 247 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 248 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 249 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 250 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 251 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 252 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 253 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 254 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 255 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 256 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 257 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 258 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 259 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 260 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 261 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 262 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 263 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 264 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 265 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 266 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 267 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 268 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 269 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 270 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 271 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 272 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 273 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 274 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 275 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 276 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 277 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 278 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 279 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 280 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 281 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 282 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 283 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 284 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 285 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 286 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 287 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 288 Bio-Rad Laboratories Inc.: Company Information
Table 289 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 290 Bio-Rad Laboratories Inc.: Company Product and Service Benchmarking
Table 291 Bio-Rad Laboratories Inc: Company Recent Developments
Table 292 Illumina Inc.: Company Information
Table 293 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 294 Illumina Inc.: Company Product and Service Benchmarking
Table 295 Illumina Inc: Company Recent Developments
Table 296 Biocept Inc.: Company Information
Table 297 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 298 Biocept Inc.: Company Product and Service Benchmarking
Table 299 Biocept Inc: Company Recent Developments
Table 300 Epigenomics A.: Company Information
Table 301 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 302 Epigenomics AG.: Company Product and Service Benchmarking
Table 303 AstraZeneca Plc.: Company Information
Table 304 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 305 AstraZeneca Plc.: Company Product and Service Benchmarking
Table 306 AstraZeneca Plc: Company Recent Developments
Table 307 Myriad Genetics Inc.: Company Information
Table 308 Myriad Genetics Inc.: Company Product and Service Benchmarking
Table 309 Myriad Genetics Inc: Company Recent Developments
Table 310 Quest Diagnostics Inc.: Company Information
Table 311 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 312 Quest Diagnostics Inc.: Company Product and Service Benchmarking
Table 313 Quest Diagnostics Inc: Company Recent Developments
Table 314 Abbott Laboratories.: Company Information
Table 315 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 316 Abbott Laboratories.: Company Product and Service Benchmarking
Table 317 Abbott Laboratories: Company Recent Developments
Table 318 Agilent Technologies Inc.: Company Information
Table 319 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 320 Agilent Technologies Inc: Company Product and Service Benchmarking
Table 321 Agilent Technologies Inc: Company Recent Developments
Table 322 Becton Dickinson and Co.: Company Information
Table 323 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 324 Becton Dickinson and Co.: Company Product and Service Benchmarking
Table 325 Becton Dickinson and Co: Company Recent Developments

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。